Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2025-12-26 @ 11:07 AM
NCT ID:
NCT02175212
Eligibility Criteria:
Inclusion Criteria:
* Histological proven adenocarcinoma of the prostate
* Stage: cT1c-3b N0M0 according to American Joint Committee on Cancer (AJCC) Tumor Node Metastasis (TNM)
* Prostatic Specific Antigen (PSA)\<100 ng/ml
* Intermediate (T1-T2 with Gleason Score \[GS\] 7 and/or PSA 10-20)
* High risk (T3 and/or GS 8-10 and/or PSA \> 20)
* Karnofsky Index (KI) performance status ≥70%
* Written informed consent
Exclusion Criteria:
* T4 N1 M1,
* Previous surgical treatment (prostatectomy or cryosurgery)
* Neoadjuvant hormonal treatment \> 3 months.
* History of pelvic radiotherapy (RT)
* Contraindications for radiotherapy
* Concomitant use of chemotherapy
* Serious psychiatric or medical condition
* Current synchronic malignancies
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02175212
Study Brief:
Protocol Section:
NCT02175212